The global mobility aid technologies market has been experiencing significant growth, reaching USD 8.5 billion in 2023 and USD 9.1 billion in 2024, with projections to expand to USD 15.40 billion by 2031 at a CAGR of 6.8%. This growth is largely driven by the aging population, which now exceeds 1.1 billion individuals aged 60 and older, and by increasing incidences of mobility-related disabilities. With 15% of the global population experiencing mobility impairments, demand for assistive technologies has surged.
Technological advancements such as AI and robotics have transformed the market. Smart wheelchairs, AI-driven devices, and robotic exoskeletons now enhance independence and accessibility for users. The robotic exoskeleton segment alone was worth USD 250 million in 2023 and grew at 15% in 2024, highlighting rapid adoption. These devices are increasingly moving from clinical use into everyday consumer applications, particularly for individuals with spinal cord injuries or severe impairments.
Regionally, North America dominates with a 35% global share in 2023, supported by strong healthcare systems and reimbursement policies. Europe follows with a 30% share, while Asia-Pacific, driven by China and Japan, shows the fastest expansion with an 8% CAGR in 2023–2024. Despite this growth, challenges remain, including regulatory hurdles, cost barriers, and the need for sustainable manufacturing. Nonetheless, the industry continues to evolve toward advanced, eco-friendly, and user-focused solutions.
The mobility aid technologies market is dominated by key countries with large aging populations, robust healthcare systems, and progressive policies. Nations such as the United States, Germany, Japan, and China drive demand through advanced infrastructure, while others like Canada, the United Kingdom, and Australia foster adoption through supportive regulations and growing investments in AI-driven mobility solutions.
Market Size: USD 3 Billion (2023) → USD 3.2 Billion (2024)
Global Share: 35%
Country-Specific Insight: The US market is driven by a senior population exceeding 75 million, with 60% of demand from healthcare institutions and 40% from individuals. Robotic exoskeletons reached USD 100 million in 2023, expanding at 12% in 2024.
Country Dynamics :
Drivers: Aging population and robust reimbursement policies
Trends: Rapid adoption of AI-driven wheelchairs and robotic exoskeletons
Restraints: High device costs and limited accessibility in rural areas
Technology Focus: Integration of robotics and AI in advanced mobility aids
Market Size: USD 1.2 Billion (2023) → USD 1.3 Billion (2024)
Global Share: 12%
Country-Specific Insight: Germany’s market is driven by its 23 million elderly population, with hospitals and elder care facilities accounting for 55% of usage. Robotic exoskeletons were valued at USD 40 million in 2023, growing 13% in 2024.
Country Dynamics :
Drivers: Strong healthcare funding and government support
Trends: Increased adoption of AI-enabled mobility aids
Restraints: High R&D costs affecting pricing strategies
Technology Focus: Focus on robotics and rehabilitation support systems
Market Size: USD 1.1 Billion (2023) → USD 1.2 Billion (2024)
Global Share: 11%
Country-Specific Insight: With over 28% of its population aged 65+, Japan has one of the highest elderly shares worldwide. Robotic exoskeletons reached USD 35 million in 2023 and expanded by 14% in 2024.
Country Dynamics :
Drivers: Government-backed elderly care policies
Trends: High penetration of robotic mobility aids
Restraints: Limited affordability outside urban regions
Technology Focus: Advanced exoskeleton development and AI-based wheelchairs
Market Size: USD 950 Million (2023) → USD 1.02 Billion (2024)
Global Share: 8%
Country-Specific Insight: The UK market benefits from NHS support, with 60% demand from institutional care. Robotic exoskeletons were valued at USD 25 million in 2023, growing 15% in 2024.
Country Dynamics :
Drivers: Government initiatives in elderly and disability care
Trends: Rising adoption of AI-driven devices in healthcare
Restraints: Budget constraints in public healthcare
Technology Focus: Advanced robotics integrated with healthcare services
Market Size: USD 850 Million (2023) → USD 900 Million (2024)
Global Share: 6%
Country-Specific Insight: With 254 million individuals aged 60+, China represents a significant market. Robotic exoskeletons accounted for USD 20 million in 2023, expanding 12% in 2024.
Country Dynamics :
Drivers: Expanding elderly population and healthcare investments
Trends: Rising adoption of smart wheelchairs in urban centers
Restraints: Uneven access across rural regions
Technology Focus: AI-enabled devices and domestic manufacturing expansion
Market Size: USD 750 Million (2023) → USD 800 Million (2024)
Global Share: 5%
Country-Specific Insight: France has over 20 million individuals aged 60+, with 55% demand from nursing homes and rehabilitation centers. Robotic exoskeletons reached USD 18 million in 2023, growing 13% in 2024.
Country Dynamics :
Drivers: Strong disability support policies
Trends: Increasing penetration of AI-based mobility aids
Restraints: Pricing constraints on advanced products
Technology Focus: Exoskeletons and smart rehabilitation devices
Market Size: USD 700 Million (2023) → USD 750 Million (2024)
Global Share: 4.5%
Country-Specific Insight: Canada’s market is driven by over 7 million elderly individuals. Robotic exoskeletons were valued at USD 15 million in 2023, growing 14% in 2024.
Country Dynamics :
Drivers: Government support for long-term care facilities
Trends: Growth in AI-powered rehabilitation devices
Restraints: Limited insurance coverage for high-cost devices
Technology Focus: Smart wheelchairs and AI-powered exoskeletons
Market Size: USD 650 Million (2023) → USD 690 Million (2024)
Global Share: 4%
Country-Specific Insight: With 13 million elderly citizens, Italy accounts for 4% of the global market. Exoskeletons were valued at USD 12 million in 2023, with 13% growth in 2024.
Country Dynamics :
Drivers: Rising aging population and disability care initiatives
Trends: Adoption of advanced mobility aids in healthcare
Restraints: High upfront cost of AI-driven solutions
Technology Focus: Rehabilitation-focused robotic solutions
Market Size: USD 600 Million (2023) → USD 650 Million (2024)
Global Share: 3.5%
Country-Specific Insight: Australia’s market is driven by 5 million individuals aged 65+, with healthcare institutions accounting for 60% demand. Exoskeletons were valued at USD 10 million in 2023, growing 15% in 2024.
Country Dynamics :
Drivers: Government support for eldercare programs
Trends: Rising adoption of advanced robotic solutions
Restraints: Limited availability in rural healthcare systems
Technology Focus: Lightweight and AI-enabled devices
The mobility aid technologies market is influenced by diverse macro factors that shape its trajectory worldwide. Political support, economic prosperity, social shifts, technological breakthroughs, environmental demands, and legal structures collectively impact industry dynamics, guiding manufacturers, policymakers, and investors toward sustainable and consumer-focused strategies.
The global mobility aid technologies market is highly competitive, with leading players focusing on innovation, AI integration, and sustainability. Companies emphasize R&D, acquisitions, and product portfolio expansion to strengthen market presence and capture growing demand from aging populations and healthcare providers.
October 2023: Sunrise Medical announced the strategic acquisition of Ride Designs in October 2023. Sunrise Medical's clinical expertise, service capabilities, manual and powered mobility devices, and custom seating offerings are anticipated to be enhanced by the acquisition.
February 2023: Reyhee, a mobility company headquartered in Los Angeles, announced in February 2023 that it has introduced two FDA-cleared, medical-grade electric vehicles: the Cruiser and the Roamer. These products provide enduring mobility solutions for individuals with disabilities and senior citizens.
The mobility aid technologies market is expanding rapidly, reaching USD 9.1 billion in 2024 and expected to hit USD 15.40 billion by 2031 at a CAGR of 6.8%. North America and Europe hold major shares due to advanced healthcare systems, while Asia-Pacific leads growth at 8% CAGR, fueled by aging populations in China and Japan. Global leaders like Invacare, Sunrise Medical, and Ottobock remain at the forefront with strong innovation pipelines.
Future market opportunities lie in AI-driven devices, robotic exoskeletons, and sustainable solutions. With the elderly population surpassing 1.1 billion in 2024, demand will surge further. Supportive government policies, inclusivity initiatives, and technological breakthroughs will ensure long-term growth, positioning the industry as a critical component of global healthcare infrastructure.